| In partnership with |  |
| & The Option Pit | Good day, 360! | Here are some of our top movers today. And take a few minutes to watch The Game Plan - we had a HUGE response from our members. Get the next Strike Zone trade today! Be the best prepared trader on the Street! | | FOCUS LIST🔎 | ALUR - Up over 50% in pre after announcing initial results on the combination of the Allurion Program With low-dose GLP-1 therapy to optimize muscle mass and GLP-1 adherence | PNBK - Up over 30% in pre after announcing over $50 Million private placement | GCTK - Up over 25% in pre after announcing it will present first-in-human study results for continuous blood glucose monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes | | *together with RYSE | This smart home company grew 200%… | | No, it's not Ring or Nest—it's RYSE, a leader in smart shade automation, and you can invest for just $1.90 per share. | RYSE's innovative SmartShades have already transformed how people control their window coverings, bringing automation to homes without the need for expensive replacements. | This year alone, RYSE has seen revenue grow by 200% year over year and expanded into 127 Best Buy stores, with international markets on the horizon. Plus, with partnerships with major retailers like Home Depot and Lowe's already in the works, they're just getting started. | Now is your chance to invest in the company disrupting home automation—before they hit their next phase of explosive growth. But don't wait; this opportunity won't last long. | Invest today at $1.90 per share and receive up to 25% bonus shares. | Past performance is not indicative of future results. Email may contain forward-looking statements. See US Offering for details. Informational purposes only. | |
|
| HOTLIST🔥 | ALUR - Up over 50% in pre after announcing initial results on the combination of the Allurion Program With low-dose GLP-1 therapy to optimize muscle mass and GLP-1 adherence | Allurion Technologies Inc. (ALUR) focuses on ending obesity with a weight loss platform to treat people who are overweight. | In the after-hours yesterday, the company announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimize muscle mass and GLP-1 adherence. | 52 patients were treated with the Allurion Balloon were started on 0.25mg semaglutide after completing their first month of balloon therapy. The dose of semaglutide was increased to no greater than 1.0mg over the subsequent 6 months. | After 8 months of this combination approach, average total body weight loss was 20.3%, and lean body mass increased by 15% from 59.6% to 68.5%. All patients remained adherent to the GLP-1 medication through 8 months. | Shares of ALUR traded up over 50% in the pre-market in reaction to the news. | | | The first target for bulls is the pre-market high at $4.18. Beyond that, $4.40, $5.58 and $6 come into play. | Below $4.18, targets to the downside are $3.80, $3.60, $3.40, $3.20, $3, $2.80 and then a gap fill at $2.28. | | PNBK - Up over 30% in pre after announcing over $50 Million private placement | Patriot National Bancorp Inc. (PNBK) operates as the holding company for Patriot Bank, N.A. that provides community banking services to individuals, small and medium-sized businesses, and professionals. | In the after-hours yesterday, the company announced that it has entered into securities purchase agreements to raise over $50 million in a private placement and agreed to issue shares of common stock and non-voting preferred stock to a diverse group of accredited investors. Net proceeds from the offering will be used to increase the equity capital and strengthen the balance sheet of Patriot National Bancorp and its wholly owned banking subsidiary, Patriot Bank NA. | Shares of PNBK traded up over 30% in the pre-market in reaction to the news. | | The $1.50 area acted as support in the pre-market and now becomes a potential level of resistance. | Above it, targets to the upside are $1.60, $1.70, $1.80, $1.90 and then the after-hours high at $2.04. Beyond that, $2.20 and $2.47 come into play. | Below $1.50, targets to the downside are $1.32, $1.20, $1.10 and then a gap fill at $1.06 with $1 below that. | | *together with Option Pit | 🔥Game Plan With Olivia Voz🔥 | "$28,688 Over 31 Trades, Averaging 92% Per Trade."* | Relive the Magic Here! |  | *Note: Trading is hard, results not guaranteed and should not be expected to be replicated typically. |
|
|
| | GCTK - Up over 25% in pre after announcing it will present first-in-human study results for continuous blood glucose monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes | GlucoTrack Inc. (GCTK) is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes in the United States. | In the after-hours yesterday, the company announced that safety and performance data from its first-in-human trial of its long-term continuous blood glucose monitoring (CBGM) system will be presented at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes (ATTD). | ATTD is an important global conference focused on technological innovations in diabetes care. The conference will be held in Amsterdam, the Netherlands, taking place March 19 – 22, 2025. | Shares of GCTK traded up over 25% in the pre-market in reaction to the news. | | The $0.50 area acted as support in the pre-market and will be an important level to watch. | Above it, targets to the upside are $0.55, $0.60, $0.65 and then the pre-market high at $0.6640. Beyond that, $0.68 and $1 come into play. | Below $0.50, targets to the downside are $0.45 and then a gap fill at $0.4135 with $0.3566 below that. | | MARKET NEWS 📰 | | | DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer | FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. | RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. | RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. | RagingBull.com, LLC shall be entitled to recover attorneys' fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys' fees, costs and disbursements in addition to any other relief to which it may be entitled. | *Sponsored Content: If you purchase anything through a link in this email other than RagingBull (RB) services, you should assume that we have an affiliate relationship with the company providing the product that you purchase, and that we will be paid in some way. Further, RYSE has previously paid RagingBull.com (RB) thirty thousand dollars in cash and thirty thousand in shares to run advertisements enhancing public awareness of the company. RB is currently invested in this company. RB is currently an affiliate for RYSE. RB is not responsible for any content hosted on affiliate's sites and it is the affiliate's responsibility to ensure compliance with applicable laws. We recommend that you do your own independent research before purchasing anything. While we believe in the companies we form affiliate relationships with, please don't spend any money on these products unless you believe they will help you achieve your goals. | WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. |
|
|
|
Tidak ada komentar:
Posting Komentar